Page last updated: 2024-10-21

4-phenyl-3-furoxancarbonitrile and Bilharziasis

4-phenyl-3-furoxancarbonitrile has been researched along with Bilharziasis in 1 studies

4-phenyl-3-furoxancarbonitrile: structure given in first source
4-phenyl-3-furoxancarbonitrile : A 1,2,5-oxadiazole substituted by an oxido, cyano and phenyl groups at positions 2, 3 and 4, respectively. It is a vasodilator and inhibitor of platelet aggregation.

Research Excerpts

ExcerptRelevanceReference
"Schistosomiasis is a chronic parasitic disease affecting hundreds of millions of individuals worldwide."1.35Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis. ( Arnér, ES; Austin, CP; Chakrapani, H; Inglese, J; Jadhav, A; Keefer, L; Lea, WA; Leister, W; Luecke, HF; Maloney, DJ; Prast-Nielsen, S; Rai, G; Sayed, AA; Shen, M; Simeonov, A; Thomas, CJ; Williams, DL, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rai, G1
Sayed, AA1
Lea, WA1
Luecke, HF1
Chakrapani, H1
Prast-Nielsen, S1
Jadhav, A1
Leister, W1
Shen, M1
Inglese, J1
Austin, CP1
Keefer, L1
Arnér, ES1
Simeonov, A1
Maloney, DJ1
Williams, DL1
Thomas, CJ1

Other Studies

1 other study available for 4-phenyl-3-furoxancarbonitrile and Bilharziasis

ArticleYear
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.
    Journal of medicinal chemistry, 2009, Oct-22, Volume: 52, Issue:20

    Topics: Animals; Biological Availability; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentratio

2009